Sublime Systems, founded by Professor Yet-Ming Chiang and former postdoc Leah Ellis, has developed a sustainable way to make one of the world’s most common materials.
Reflecting a “Moore’s Law of aviation,” commercial flight has become roughly twice as safe each decade since the 1960s; Covid-19 added a wrinkle, however.
By designing new tools that can analyze huge libraries of immune cells and their targets, Michael Birnbaum hopes to generate better T cell therapies for cancer and other diseases.
Alnylam Pharmaceuticals, founded by MIT professors and former postdocs, has turned the promise of RNAi research into a new class of powerful therapies.